Study on the Effects of Intravenous Dexmedetomidine on Pain in Patients Undergoing Elective Spinal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

September 14, 2016

Primary Completion Date

February 22, 2022

Study Completion Date

February 22, 2022

Conditions
Chronic Pain
Interventions
DRUG

Dexmedetomidine

The drug will be administered with a loading dose of 0.5 mcg/kg given over 20 min followed by an infusion at 0.6 mcg/kg/hr. The infusion will be stopped during closure of the fascia.

OTHER

Placebo Saline

Placebo will be administered with a loading dose of 0.5 mcg/kg given over 20 min followed by an infusion at 0.6 mcg/kg/hr. The infusion will be stopped during closure of the fascia.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03325972 - Study on the Effects of Intravenous Dexmedetomidine on Pain in Patients Undergoing Elective Spinal Surgery | Biotech Hunter | Biotech Hunter